Biologics (mepolizumab and omalizumab) induced remission in severe asthma patients

- Thomas, Dennis, McDonald, Vanessa M., Gillman, Andrew, Hew, Mark, Hodge, Sandra, James, Alan, Jenkins, Christine, Katelaris, Constance H., Katsoulotos, Gregory P., Langton, David, Lee, Joy, Marks, Guy, Stevens, Sean, Peters, Matthew, Radhakrishna, Naghmeh, Reynolds, Paul N., Rimmer, Janet, Sivakumaran, Pathmanathan, Upham, John W., Wark, Peter, Yang, Ian A., Gibson, Peter G., Harvey, Erin S., Baraket, Melissa, Bardin, Philip, Bowden, Jeffrey J., Bowler, Simon, Chien, Jimmy, Chung, Li Ping

Comorbidities Modify the Phenotype but Not the Treatment Effectiveness to Mepolizumab in Severe Eosinophilic Asthma

- Kritikos, Vicky, Harvey, Erin S., Thomas, Dennis, Gibson, Peter G., Australian Mepolizumab Registry Investigators,, Stevens, Sean, Katelaris, Constance H., Langton, David, Rimmer, Janet, Farah, Claude S., Gillman, Andrew, Hew, Mark, Radhakrishna, Naghmeh

Work-related asthma: a position paper from the thoracic society of Australia and New Zealand and the national asthma council Australia

- Hoy, Ryan, Burdon, Jonathan, Zosky, Graeme, Chen, Ling, Miles, Susan, Perret, Jennifer L., Prasad, Shivonne, Radhakrishna, Naghmeh, Rimmer, Janet, Sim, Malcolm R., Yates, Deborah